Taken together, these lines of evidence make GLP1 drugs a plausible strategy to test in obesitylinked prostate cancer, and at least one prospective trial of GLP1 receptor agonists in men on androgendeprivation therapy is now registered, but the weightloss jabs slow prostate cancer spread by blocking fattumour crosstalk story remains an informed hypothesis rather than a completed, peerreviewed study
This structured approach supports safe continuation of PT-141 and informed decision-making throughout treatment
For those who do discontinue, maintaining weight loss requires aggressive lifestyle strategies: high protein intake (1.01.6 g per kg of body weight daily), consistent resistance training, and ongoing monitoring
( Comment: Some commenters expressed concern that CMS underestimated the amount of time and burden it will take hospitals to collect, organize, properly format, calculate, update and report the median payer-specific negotiated charges by MS-DRG
Natural fertility support for men falls under a few simple categories